MedPath

Effect of N-Acetyl cysteine on the success rate of H.pylori eradicatio

Phase 2
Conditions
Helicobacter pylori.
Helicobacter pylori [H.pylori] as the cause of diseases classified to other chapters
Registration Number
IRCT2012121511738N2
Lead Sponsor
Vice Chancellor for Research of Tabriz University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
230
Inclusion Criteria

patients older than 20 years old, HP positive patients at the time of an injection molded pylori eradication indicated they have not previously received eradication regimen, the patients who have NAC in past month.
Exclusion criteria: history of gastrectomy, gastric cancer includes adenocarcinoma, previous allergic reaction to antibiotics (amoxicillin and clarithromycin), NAC and proton pump inhibitors (omeprazole), pregnant and lactating women, concurrent severe illness, phenyl ketone Avery, taking antibiotics or NAC now or in the past month and is patient's dissatisfaction.

Exclusion Criteria

Not provided

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
The success rate of H pylori eradication regimen. Timepoint: One month after treatment. Method of measurement: Test.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath